Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Avastin is a medication used in eye care to block a substance called vascular endothelial growth factor (VEGF). When injected into the eye, it helps reduce swelling and leakage caused by abnormal blood vessel growth. It was originally developed for cancer treatment, but eye specialists also use it for retinal conditions. Many patients receive it as part of ongoing care.
read more about avastin ...Avastin helps manage conditions where abnormal vessels affect central vision. It reduces fluid buildup in the retina, which can improve clarity and comfort. Eye specialists often choose it because it has a strong effect on vessel growth. It is also widely available across clinics.
The medication is injected into the vitreous, the clear gel inside the eye. It blocks VEGF, which helps limit leakage and unwanted vessel growth. This can stabilize or improve vision over a series of treatments. Doses are scheduled based on how the retina responds.
Other anti-VEGF medications work similarly but may differ in formulation or cost. Avastin is often chosen because it is accessible and widely used. Some patients respond differently to each medication, so providers adjust treatment based on results. All of these medications share the same goal of reducing leakage and vessel growth.
The eye is numbed so the injection feels like brief pressure rather than pain. The procedure is quick and done in the clinic. Mild irritation or watering may follow but usually fades soon. Follow-up visits help determine whether more doses are needed.
It works in a similar way because it blocks VEGF to reduce leakage and abnormal vessel growth. The differences are often related to formulation, pricing, and how clinics source it for eye use. Some patients respond better to one anti-VEGF medication than another. Doctors adjust based on retinal scans and treatment response.
Some people notice changes within weeks, especially if swelling drops. Others see stability first, with gradual improvement over multiple doses. The condition being treated and how long swelling has been present matter a lot. Regular imaging helps show whether the retina is drying and flattening over time.
It depends on the condition and your response. Many plans start with monthly injections, then spacing out if the retina stays stable. Some patients need more frequent treatment if leakage returns. Your specialist sets the schedule based on follow-up exams and imaging.
Most people can go back to daily routines, but it's smart to avoid rubbing the eye. Your provider might advise skipping swimming or dusty environments for a short time to reduce infection risk. Vision may be a bit blurry from dilation or surface irritation, so driving right after can be a bad idea. If you're unsure, follow the clinic's post-injection instructions.
1. Avastin (bevacizumab) Prescribing Information. U.S. Food and Drug Administration (FDA) Drugs@FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/. Accessed January 29, 2026.
2. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration (CATT). PubMed (National Library of Medicine). https://pubmed.ncbi.nlm.nih.gov/21526923/. Accessed January 29, 2026.
3. Intravitreal Injections. American Society of Retina Specialists (ASRS). https://www.asrs.org/patients/retinal-treatments/5/intravitreal-injections. Accessed January 29, 2026.
4. Age-Related Macular Degeneration (AMD) and Anti-VEGF Injections (Patient Overview). American Academy of Ophthalmology (AAO). https://www.aao.org/eye-health/diseases/amd-macular-degeneration. Accessed January 29, 2026.
5. Intravitreal Bevacizumab (Clinical Overview). EyeWiki (American Academy of Ophthalmology). https://eyewiki.org/Intravitreal_Bevacizumab. Accessed January 29, 2026.
6. Bevacizumab (Avastin) for Retinal Disease (Background). Merck Manual Professional Edition. https://www.merckmanuals.com/professional. Accessed January 29, 2026.